Notch Therapeutics

David Main, President and CEO

Oct. 10 | 11:00am | Rentschler ATMP Ballroom 

Vancouver, BC


Notch is working to broaden the applicability and increase accessibility of cell therapy as a medicine through our unprecedented production of functional T cells from iPSCs and our proprietary, scalable, small-footprint manufacturing systems that use precision control of notch signaling. 

By using this website you agree to accept our Privacy Policy and Terms & Conditions